Skip to main content

ClearPoint Neuro, Inc.

CLPT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001285550

No open-market purchases or sales by ClearPoint Neuro, Inc. insiders were filed in the last 90 days; 128 institutions reported holding it in 13F filings for Q2 2026, worth $247.8M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding ClearPoint Neuro, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of CLPT: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders5662+6
Shares3.82M4.23M+409.0K (+10.7%)
Value$39.6M$36.0M−$3.61M (−9.1%)

New holders (15)

Institutions that held ClearPoint Neuro, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to CLPT in Q4 2022
InstitutionSharesValue% of portfolio
Legato Capital Management LLC62,562$529.9K0.10%
Renaissance Technologies LLC49,337$418.0K0.00%
Mayo Clinic38,114$322.8K0.17%
683 Capital Management, LLC19,362$164.0K0.01%
Marshall Wace, LLP18,046$152.8K0.00%
Man Group plc15,124$128.1K0.00%
Balyasny Asset Management LLC14,361$121.6K0.00%
Price T Rowe Associates Inc14,000$119.0K0.00%
Boothbay Fund Management, LLC11,074$93.8K0.00%
Mirabella Financial Services LLP10,328$87.5K0.01%
Lighthouse Investment Partners, LLC10,130$85.8K0.02%
Simplex Trading, LLC5,884$49.0K0.00%
State of Wyoming2,927$24.8K0.01%
Advisory Services Network, LLC800$6.78K0.00%
Cornerstone Planning Group LLC38$3750.00%

Sold out (9)

Institutions that held ClearPoint Neuro, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of CLPT in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
EAM Investors, LLC113,220$1.17M
Ergoteles LLC71,322$739.0K
Assenagon Asset Management S.A.50,935$528.0K
Smith Anglin Financial, LLC20,000$207.0K
Ancora Advisors, LLC14,000$145.0K
Castle Wealth Management LLC2,000$21.0K
IFP Advisors, Inc904$8.00K
Royal Bank of Canada404$4.00K
Harbour Investments, Inc.125$2.00K